Annovis Bio Shares Drop Over 27% Following Announcement of Public Offering
Annovis Bio (ANVS) experienced a significant stock price decline of more than 27% on Wednesday. The sell-off was triggered by the company's announcement regarding a proposed public offering consisting of common stock and accompanying warrants. The offering involves issuing shares of common stock and warrants separately. Such capital raises often lead to immediate share price dilution, which typically results in downward pressure on existing equity as investors react to the increased supply of shares.